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Proteolysis is a key regulatory process that promotes
the (in)activation, translocation, and/or degradation
of proteins. As such, there is considerable interest
in methods to comprehensively characterize proteo-
lytic pathways in biological systems. Here, we de-
scribe a robust and versatile proteomic platform
that enables direct visualization of the topography
andmagnitudeofproteolytic eventsonaglobal scale.
We use this method to generate a proteome-wide
map of proteolytic events induced by the intrinsic
apoptotic pathway. This profile contained 91 charac-
terized caspase substrates as well as 170 additional
proteins not previously known to be cleaved during
apoptosis. Surprisingly, the vast majority of proteo-
lyzed proteins, regardless of the extent of cleavage,
yielded persistent fragments that correspond to dis-
crete protein domains, suggesting that the genera-
tion of active effector proteins may be a principal
function of apoptotic proteolytic cascades.
INTRODUCTION
Proteases constitute 1%–5% of eukaryotic genomes, with the
human genome, in particular, encoding 566 predicted proteo-
lytic enzymes (Puente et al., 2003). The functions of proteases
are essential in many physiological processes, including devel-
opment (Matrisian and Hogan, 1990; Turgeon and Houenou,
1997), blood coagulation (Riewald and Ruf, 2001), and cell death
(Alnemri, 1997), as well as many pathological events such as
cancer (van Kempen et al., 2006) and infectious disease (Ab-
del-Rahman et al., 2004). Even the most well-studied proteolytic
cascades remain only partially understood, and a large portion
of human proteases is wholly uncharacterized with respect to
endogenous substrates and biological functions. These gaps in
our knowledge of protease biology have inspired the develop-
ment of proteomic methods to profile protease-substrate rela-
tionships on a global scale (auf dem Keller et al., 2007). These
efforts can be divided into three general categories. The first isin vitro specificity profiling experiments such as peptide, phage,
and bacterial display, in which a purified protease of interest is
exposed to a large library of peptides/proteins to identify sub-
strates (Harris et al., 2000; Ju et al., 2007; Kridel et al., 2001; Mat-
thews and Wells, 1993). While these studies often yield valuable
insight into the sequence specificity of proteases, interpretation
of the biological significance of results is difficult given that the
protease-substrate interactions occur in an artificial environment
that differs substantially from natural biological systems. A
second approach utilizes two-dimensional gel electrophoresis
(2-DGE), where differences in the migration and intensity of
cleaved substrates are detected by protein staining following ac-
tivation or addition of a protease to a biological sample (Brede-
meyer et al., 2004; Brockstedt et al., 1998; Gerner et al., 2000;
Lee et al., 2004). This approach has the advantage of identifying
substrates for proteases in endogenous settings. Although 2-
DGE experiments and second-generation technologies built on
this method have proven extremely valuable and are still in com-
mon practice, they suffer from issues of reproducibility, through-
put, and sensitivity (Corthals et al., 2000; Gygi et al., 2000).
Neither peptide/protein display nor 2-DGE methods yields di-
rect information on the sites of endogenous proteolytic cleavage.
To address this limitation, a third set of proteomic technologies
has emerged that uses chemical labeling strategies to capture
emergent N termini from protease cleavage events (Dean and
Overall, 2007; McDonald et al., 2005; Timmer and Salvesen,
2006; Van Damme et al., 2005). A number of variations on this
technique have been introduced, including those that permit se-
lective separation and/or enrichment of the cleaved N-terminal
peptides (Dean and Overall, 2007; McDonald et al., 2005; Timmer
et al., 2007). However, all such N-terminal labeling approaches
possess drawbacks. Most notably, these methods, which profile
only a single peptide from the C-terminal portion of cleaved pro-
teins, do not provide any topographical information about proteo-
lytic cleavage events. As such, no data are acquired on whether
the cleaved portions of proteins remain intact or are further de-
graded. This is particularly problematic for N-terminal fragments
of protease substrates, since robust and selective C-terminal
labeling strategies have not yet been developed. Furthermore,
the intact parent protein often goes undetected (due to N-terminal
modifications thatare prevalent onnativeproteins), and, therefore,
the magnitude of proteolytic cleavage remains unknown. Finally,Cell 134, 679–691, August 22, 2008 ª2008 Elsevier Inc. 679
Figure 1. General Methodological Features of PROTOMAP
Proteomes from control and experimental systems are separated by 1D SDS-PAGE and the gel lanes cut into bands at fixed intervals. Bands are digested with
trypsin to release peptides that are analyzed by 1D reverse-phase LC-MS/MS. The resulting proteomic data are integrated into peptographs, which plot, in the left
panel, sequence coverage for a given protein in the horizontal dimension (N to C terminus, left to right) versus SDS-PAGE migration in the vertical dimension (high
to low molecular weight [MW], top to bottom). In the right panel, the peptograph also displays average spectral counts for each protein in each gel band. Proteins
that undergo proteolytic cleavage are identified by shifts in migration from higher (parental, red) to lower (fragments, blue) MW species in control versus
experimental systems. The sequence coverage shown in the peptograph provides a topographical map of the protein fragments that persist following proteolysis.
The magnitude of proteolysis is estimated by comparing spectral counts of the parental protein in control versus experimental proteomes.from a technical perspective, detection of cleavage is contingent
on the identification of a single peptide, which, considering the
small number of proteotypic peptides observed in most proteins
(i.e., those peptides that can reliably be identified by LC-MS/MS;
Craig et al., 2005; Kuster et al., 2005), likely results in substantial
numbers of protease substrates remaining undetected.
Given the aforementioned limitations of current proteomic ap-
proaches, the challenge of comprehensively determining the
magnitude and topography of protein cleavage events, which
is essential to predict the functional consequences of proteoly-
sis, still typically requires the time-consuming and costly process
of generating multiple antibodies that recognize epitopes
throughout the sequences of individual proteins. To address
this problem on a global scale, we describe herein a robust,
high-content proteomic platform to profile proteolytic events oc-
curring in natural biological systems termed Protein Topography
and Migration Analysis Platform (PROTOMAP). We have applied
this technology to the well-studied intrinsic apoptosis pathway in
Jurkat T cells, resulting in the identification of many established
caspase-mediated proteolytic events and more than 150 addi-
tional proteins not previously documented as being cleaved
during apoptosis. PROTOMAP further yields a number of
provocative conclusions about the general impact of proteolysis
on the structural architecture of proteins in apoptotic cells.
RESULTS
PROTOMAP Methodology
SDS-PAGE is a routine method for protein fractionation and
serves the purpose of reducing sample complexity prior to MS
analysis in proteomics investigations. SDS-PAGE also reveals
information about the molecular mass of proteins; however, this
information has rarely been systematically taken into account in
large-scale proteomic experiments, even in cases where upfront
SDS-PAGE fractionation steps were performed (Li et al., 2007;
Lohaus et al., 2007; Shi et al., 2007). Therefore, we developed680 Cell 134, 679–691, August 22, 2008 ª2008 Elsevier Inc.PROTOMAP with the goal of integrating SDS-PAGE migratory
rates with sequence coverage and spectral count values acquired
by LC-MS/MS to provide a rich set of data that could reveal global
changes in the size, topography, and abundance of proteins in
complex biological samples (Figure 1). To accomplish this integra-
tion and facilitate interpretation of results, we developed an algo-
rithmthat translatesSDS-PAGEandLC-MS/MSdata intoaunique
visual format for data representation, referred to as a ‘‘pepto-
graph.’’ A typical PROTOMAP experiment begins with compari-
son of control and experimental samples by separation by
one-dimensional (1D) SDS-PAGE. Each sample lane is then sliced
into gel bands at fixed intervals (typically 0.5 cm), and these bands
are digested with trypsin to release peptides that aresubsequently
analyzed by 1D reverse-phase LC-MS/MS. The resulting proteo-
mic data from all of the gel bands are translated into peptographs,
which plot sequence coverage for a given protein in the horizontal
dimension (N to C terminus, left to right) and SDS-PAGE migration
in the vertical dimension (high to low molecular weight, top to bot-
tom) (Figure 1). Control and experimental samples are distin-
guished in the peptograph by color (red and blue, respectively,
with purple representing overlapping sequence coverage). Semi-
quantitative analysis of each band is provided by ‘‘spectral count-
ing’’ (a common method for quantitation in which spectra that
match each peptide are counted to provide an estimate of their
abundance) in a chart on the right side of each peptograph.
The comparative analysis of normal and apoptotic cells was
expected to offer an excellent model system with which to test
the sensitivity, precision, and utility of PROTOMAP for multiple
reasons. First, caspase-mediated proteolytic cascades that me-
diate this process have been intensively studied and are known
to generate numerous protein cleavage events (Fischer et al.,
2003; Luthi and Martin, 2007; Timmer and Salvesen, 2006).
Furthermore, the molecular pathways that contribute to apopto-
sis, an event of high relevance to many physiological and patho-
logical processes, are only partially understood (Abud, 2004;
Cowan et al., 1984; Kerr et al., 1994).
Figure 2. Established Markers of Apoptotic Proteolytic Pathways Visualized by PROTOMAP
(A and B) Apoptosis was induced in Jurkat T cells by treatment with staurosporine (STS) for 4 hr, which produced DNA fragmentation (A) and caspase 3 cleavage
(B). Cleavage of caspase 3 is evident from the peptograph (B, right panels), which identified peptides for the 32 kDa proform of this protease in control cells (red
signals, bands 15 and 16) and peptides for the 12 and 17 kDa activated forms in STS-treated cells (blue signals, bands 21 and 22). Peptides detected in both
samples are shown in purple.
(C) Cleavage of ROCK1 (parental species, 158 kDa) to 130 and 28 kDa fragments.
(D and E) Cleavage of PARP1 in STS-treated cells. Parental PARP1 was found in the particulate fraction of control cells (D) and, upon induction of apoptosis, was
detected in the soluble fraction as a series of cleaved fragments (E). The asterisk in the PARP1 western blot of the particulate fraction likely corresponds to
antibody crossreactivity with a background protein, since no spectral counts for PARP1 were detected in the corresponding gel band. Notably, a number of
fragments of PARP1 that are not observed by immunoblotting were evident from the peptographs. This likely reflects the restricted epitopes recognized by
anti-PARP1 antibodies.
(F) Peptographs for representative members of the COPS family, showing selective cleavage of COPS6 in apoptotic cells, as previously demonstrated (da Silva
Correia et al., 2007). Peptographs for all nine members of the COPS family can be found in Figure S2.
Spectral count data are represented as the mean ± SEM for four independent experiments.Characterization of Established Proteolytic Markers
of Apoptosis
The intrinsic apoptosis pathway was induced in Jurkat T cells by
incubation with the pan-kinase inhibitor staurosporine (STS) for
4 hr. This time point was chosen because it represents an estab-
lished midpoint in the Jurkat apoptosis time course (Feng andKaplowitz, 2002; Na et al., 1996), which we confirmed by moni-
toring DNA fragmentation and caspase 3 activation (Figures 2A
and 2B, respectively). Cells were lysed, and the soluble pro-
teomes (100 mg protein/sample) from control and apoptotic cells
were resolved by 1D-SDS-PAGE (10% polyacrylamide). Gel
lanes were then cut into 22 bands (0.5 cm vertical length), andCell 134, 679–691, August 22, 2008 ª2008 Elsevier Inc. 681
each band was subjected to in-gel trypsin digestion and ana-
lyzed by LC-MS/MS and the SEQUEST algorithm, which iden-
tifies peptides from their MS2 spectra (Eng et al., 1994). Data
from the entire collection of gel bands (176 bands in total: two
samples with four replicates each) were converted to individual
peptographs for each protein identified in the experiment (all
peptographs can be viewed online at http://www.scripps.edu/
chemphys/cravatt/protomap). Manual inspection of the resulting
peptographs showed that known markers of apoptosis displayed
expected patterns of cleavage, including caspase 3, a principal
effector caspase (Cohen, 1997), which shifted from the 32 kDa
proform in control samples (bands 15 and 16) to the active dimer
comprised of 12 and 17 kDa species in apoptotic samples (bands
21 and 22, Figure 2B). Notably, even though the latter two species
were not resolved on a 10% polyacrylamide gel, clear evidence of
their mutual existence was provided by examination of the cas-
pase 3 peptograph, which displayed sequence coverage span-
ning both the N- and C-terminal fragments of the enzyme in
bands 21 and 22 of STS-treated cells (Figure 2B). Several other
caspases were detected by PROTOMAP, including caspases
2, 6, 7, and 8, all of which underwent proteolytic cleavage in
STS-treated cells (Figure S1 available online).
Caspase 3 is known to cleave the Rho-associated protein ki-
nase, ROCK1, near the C terminus at aspartate 1113 of a
DETD consensus sequence (Coleman et al., 2001), releasing
a 28 kDa autoinhibitory domain and generating a constitutively
active 130 kDa form of the kinase (Jin and El-Deiry, 2005). The
ROCK1 peptograph showed the parental protein migrating pri-
marily in band 2 in control cells, corresponding to a molecular
mass range of 150–200 kDa (full-length ROCK1 is 158 kDa)
(Figure 2C). Upon induction of apoptosis, two major fragments
of ROCK1 were observed that corresponded to the larger N-ter-
minal fragment in band 3 (mass range of 125–150 kDa) and
smaller C-terminal fragment in band 17 (mass range of 25–30
kDa). Further examination of the peptographs pointed to
D1113 as the implicit site of cleavage (Figure 2C). Notably, the
parental and active kinase forms of ROCK1 were clearly resolved
into separate gel bands (2 and 3, respectively), despite showing
less than a 20% change in mass.
Another prototypical marker of apoptosis is cleavage of poly-
(ADP)ribose polymerase 1 (PARP1) (Zong et al., 2004). PARP1 is
a 113 kDa enzyme involved in DNA repair that is inactivated by
caspase 3 during apoptosis. Under normal conditions, PARP1
is bound to DNA in the nucleus and, therefore, did not appear
in the soluble fraction of control cells (although strong signals
were observed for PARP1 in band 4 of the particulate fraction
of control cells, corresponding to a mass range of 100–125
kDa; Figure 2D). Upon STS treatment, multiple cleaved frag-
ments of PARP1 were released into the soluble fraction of Jurkat
cells, including a strong 89 kDa fragment (band 5), which was
confirmed by western blotting (Figure 2E).
To provide evidence that PROTOMAP can accurately discrim-
inate cleaved from noncleaved proteins, we examined pepto-
graphs for the eight subunits of the COP9 signalosome. The 39
kDa COPS6 subunit of this protein complex has recently been
found to undergo caspase-mediated cleavage to generate a 36
kDa C-terminal fragment (da Silva Correia et al., 2007). Other
signalosome subunits did not show evidence of proteolytic682 Cell 134, 679–691, August 22, 2008 ª2008 Elsevier Inc.cleavage in this previous study. We observed essentially identi-
cal results in the PROTOMAP comparison of control and STS-
treated Jurkat cells: all eight signalosome components were
identified in bands consistent with their predicted molecular
masses, but only COPS6 showed a shift in migration to a lower
band in apoptotic cells (from band 14 to 15; Figures 2F and
S2). This finding, in combination with the aforementioned data
for ROCK1, underscores the remarkable resolution achievable
by PROTOMAP, which can detect 10%–20% changes in protein
size across a large mass range (i.e., 20–200 kDa).
Global Analysis of Proteolytic Events in Apoptosis
To comprehensively annotate proteins cleaved during apopto-
sis, we developed an algorithm termed PROTOSort to identify
peptographs with altered signal intensities and/or gel migration
patterns in control versus STS-treated cells (Supplemental Ex-
perimental Procedures). Using PROTOSort, we identified 261
proteins predicted to undergo cleavage or substantial downre-
gulation in apoptotic cells out of a total of 1648 proteins detected
with sufficient spectral counts to permit quantitative analysis (a
complete list of these predicted cleaved proteins is provided in
Table S1). No reduction in sensitivity was observed for detection
of proteolytically cleaved proteins compared to noncleaved pro-
teins, as evidenced by the equivalent distribution of spectral
counts for proteins from each class (Figure S3).
Searches of the public literature and the Caspase Substrate
Database Homepage (CASBAH) (Luthi and Martin, 2007)
revealed that 91 of the predicted cleaved proteins identified by
PROTOMAP corresponded to known caspase substrates
(Figure 3A and Table S1). The large number of additional proteins
that displayed altered migration patterns in STS-treated cells
suggested that PROTOMAP uncovered many heretofore un-
known proteolytic events in apoptosis. Proteins known to be
cleaved in apoptosis were detected with high spectral count
values compared to previously unknown cleavage events
(Figure 3B), suggesting that sensitivity has played a limiting
role in the historical characterization of apoptotic proteolytic
pathways. Western blotting analysis was used to confirm repre-
sentative examples of predicted proteolytic events. JMJDB1,
a putative histone demethylase, shifted from a parental 191 kDa
protein (bands 1/2) in control cells to persistent 75 kDa N- and
100–125 kDa C-terminal fragments (bands 3 and 6, respectively)
in STS-treated cells (Figure 3C). An equivalent migration pattern
was observed for JMJDB1 by western blotting (Figure 3C).
Similarly, the peptograph for MAP2K2, a 45 kDa member of the
mitogen-activated protein kinase family, identified an N-terminal
30 kDa persistent fragment in apoptotic cells (band 16), which
was also observed by western blotting (Figure 3D).
Estimation of the Magnitude of Protein Cleavage Events
Numerous studies have confirmed the accuracy of spectral
counting as an MS-based method for the relative quantitation
of protein abundances in biological samples (Dong et al., 2007;
Liu et al., 2004; Old et al., 2005). Therefore, we used this param-
eter to estimate the magnitude of protein cleavage events in ap-
optotic cells. The right panel of each peptograph reports average
spectral count values for each protein in each band of the gel.
Assuming that the slowest migrating species in each peptograph
Figure 3. Global Analysis of Cleaved Proteins in Apoptotic Cells
(A) A total of 261 predicted cleaved proteins were identified by PROTOMAP in apoptotic cells, 91 (35%) of which corresponded to established caspase substrates
and/or proteins known to be proteolyzed during apoptosis. The remaining 170 proteins (65%) were not previously known to be cleaved during apoptosis.
(B) Comparison of the spectral count values for previously known versus unknown cleaved proteins in apoptotic cells. Note that proteins with high spectral count
values were predominantly from the former group.
(C and D) Examples of predicted cleaved proteins that were confirmed by western blotting. In the case of JMJD1B (C), an implicit caspase cleavage sequence at
amino acids 817–823 (tandem DLSD) could be identified that resided between the persistent 75 kDa N- and 100–125 kDa C-terminal fragments. In the case of
MAP2K2 (D), the explicit caspase cleavage site was identified by PROTOMAP at residue D284. The asterisk in the MAP2K2 western blot likely corresponds to
antibody crossreactivity with a background protein, as no spectral counts were detected for MAP2K2 in the corresponding gel band.
Spectral count data are represented as the mean ± SEM for four independent experiments.corresponds to the parental form of the protein (a premise that is
supported by a global comparison of the predicted and mea-
sured masses for proteins identified by PROTOMAP; Figure S4),
we then asked whether these values provide an accurate esti-
mate of the extent of degradation of the parental protein in apo-
ptotic cells. Cleaved proteins were divided into three general
classes based on the predicted magnitude of cleavage of the
parental species: class I, near-complete degradation (<20%
spectral counts remaining in STS-treated cells); class II, moder-
ate degradation (20%–80% spectral counts remaining in STS-
treated cells); and class III, minor degradation (>80% spectral
counts remaining in STS-treated cells). These classes were rep-
resented with similar frequencies, comprising 31%, 39%, and
30% of the predicted cleaved proteins, respectively (Figure 4A).
Representative examples of class I and II proteins were exam-
ined by western blotting, which corroborated the predictions
made by spectral counting. For two class I proteins, PAK2 and
Vimentin, negligible signals were observed by western blotting
for the parental protein in STS-treated cells (Figures 4B and
4C, respectively). In contrast, strong western signals were ob-
served for the parental forms of the class II proteins TRIM28
and MAP2K1 in apoptotic cells (Figures 4D and 4E, respectively).It is also interesting to note that, in three of the four cases (PAK2,
Vimentin, and TRIM28), persistent protein fragments were
detected by PROTOMAP that were not observed by western
analysis. This finding likely reflects the restricted number of
epitopes recognized by most antibodies and underscores the
ability of PROTOMAP to provide a more complete topographical
description of protein fragments in proteomes.
Generation of Detailed Topographical Maps
of Cleaved Proteins
A striking feature of the PROTOMAP data set was the prevalence
of cleaved proteins that generated stable or persistent fragments
in apoptotic cells. Indeed, a global analysis revealed that >95%
of the predicted cleaved proteins displayed at least one persis-
tent fragment (Figure 5A). This high percentage was observed
for all three classes of parental degradation (Figure S5), indicat-
ing that even proteins whose parental forms underwent com-
plete degradation tended to show persistent fragments. The
persistent fragments observed in apoptotic cells derived from
essentially all possible topographical classes: (1) N-terminal
(25%), (2) C-terminal (13%), (3) N- and C-terminal (21%), and
(4) internal (23%) (Figure 5A). Representative examples of eachCell 134, 679–691, August 22, 2008 ª2008 Elsevier Inc. 683
Figure 4. Estimation of the Magnitude of Protein Cleavage Events in Apoptotic Cells
(A) Predicted cleaved proteins were divided into three general classes: near-complete (class I, <20% spectral counts remaining in STS-treated cells), moderate
(class II, 20%–80% spectral counts remaining in STS-treated cells), and minor (class III, >80% spectral counts remaining in STS-treated cells) degradation of the
parental species.
(B and C) Western blot confirmation that class I proteins PAK2 (B) and Vimentin (C) underwent near-complete degradation in apoptotic cells.
(D and E) Western blot confirmation that the class II proteins TRIM28 (D) and MAP2K1 (E) were only partially degraded in apoptotic cells. The bar graph to the right
of each peptograph represents total spectral counts detected for the parental species in control (red) and apoptotic (blue) samples.
Spectral count data are represented as the mean ± SEM for four independent experiments.class are shown in (B)–(E) of Figure 5. Many of the persistent frag-
ments mapped to domains that are known to form stably folded
and functional modules, such as the SH3, HEAT, and C2 do-
mains shown for the proteins DOCK2, CLASP2, and FAM62a, re-
spectively (Figures 5B, 5D, and 5E, respectively, and Table S1).
Not all domains, however, were preserved in apoptotic cells,
even in cases where the same domain was repeated multiple
times in an individual protein (e.g., RBM39, which contains three
RRM domains, only one of which persisted in apoptotic cells;
Figure 5C). Clear instances were also found of persistent frag-
ments that did not contain known protein domains, such as the
C-terminal portion of the splicing factor SF3B2 (Figure S8). It is
interesting to speculate that these fragments may correspond
to protein domains not yet recognized by current search algo-
rithms. These data collectively suggest that apoptotic proteolytic
cascades do not, in general, affect the complete degradation of
proteins but, rather, generate new forms of these proteins.684 Cell 134, 679–691, August 22, 2008 ª2008 Elsevier Inc.Temporal Stability of Persistent Fragments
That persistent fragments were observed for many proteins
whose parental species were completely degraded suggested
that the lifetime of these fragments is substantial and that they
may represent functional effectors rather than transient interme-
diates en route to total degradation. To more thoroughly investi-
gate the temporal stability of persistent fragments, we analyzed
cells at multiple time points during the apoptotic cascade.
PROTOMAP analyses were conducted at 2, 4, and 6 hr following
STS treatment, as these time points were found to bracket the
early and late stages of apoptosis as judged by DNA fragmenta-
tion, caspase 3 activation, and PARP1 cleavage (Figure S7). The
rate of degradation of proteins displaying persistent fragments
varied widely, with roughly 52% and 33% of these proteins
undergoing rapid and slow degradation, respectively (Figure 6A).
More striking, however, was the stability of the persistent frag-
ments of cleaved proteins. Indeed, more than one-third of these
Figure 5. Visualization of the Topography of Protein Cleavage Events in Apoptotic Cells
(A) The vast majority (>95%) of cleaved proteins generated at least one persistent fragment in apoptotic cells. Essentially all possible topographical classes of
fragments were observed: (1) N-terminal (25%), (2) C-terminal (13%), (3) N- and C-terminal (21%), and (4) internal (23%). ‘‘Unclear’’ refers to cleaved proteins with
fragments that could not be obviously assigned to one of the other four fragment classes.
(B–E) Peptographs for representative examples of N-terminal (B), C-terminal (C), N- and C-terminal (D), and multiple/internal (E) fragments. Predicted domain
structures for each protein are shown below each peptograph to highlight the fact that most persistent fragments map to functional protein domains.
Spectral count data are represented as the mean ± SEM for four independent experiments.proteins displayed stable fragments that persisted at all three
time points (Figures 6B and 6C). The vast majority of the remain-
ing proteins displayed fragments of intermediate stability that
were detected at two consecutive time points but absent from
a third, thereby demonstrating lifetimes of at least 2 hr (Figures
6B and 6D). These intermediate fragments could be further
subdivided into those that were observed early (2 and 4, but
not 6 hr) versus late (4 and 6, but not 2 hr) in the time course.
The majority of intermediate fragments fell into the latter cate-gory, likely representing slowly accumulating fragments rather
than fragments proceeding toward complete degradation. Only
12% of cleaved proteins displayed transient fragments that
were detected exclusively at a single time point (Figures 6B
and 6E). Strikingly, many proteins that were rapidly degraded
displayed stable fragments that persisted throughout all time
points (Figures 6C and S7D and Table S3). In fact, stable persis-
tent fragments were detected with overall higher frequency
among the rapid- versus slow-degradation proteins (40% versusCell 134, 679–691, August 22, 2008 ª2008 Elsevier Inc. 685
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24%, respectively; Figure S7D). Collectively, these time course
data further support the premise that apoptotic proteolytic path-
ways commonly generate new, stable forms of proteins rather
than affect their total degradation and clearance.
Identification of Explicit Sites of Proteolytic Cleavage
A prominent goal for technologies aiming to map proteolytic
pathways is to determine the precise sites of protein cleavage
(Schilling and Overall, 2007). Although PROTOMAP was not orig-
inally designed for the goal of detecting explicit sites of cleavage,
thorough examination of our data revealed a surprising number
of half-tryptic peptides where one terminus was defined by an
aspartic acid residue that fell on the boundary of a persistent
fragment. We detected 74 such peptides, corresponding to 68
unique cleavage events in 61 proteins (Table S4). A number of
peptides spanning and bordering such scissile residues were
hand sequenced to ensure valid assignment. A representative
example is shown in Figure 7 for the protein U2AF2, where a pep-
tide spanning the cleavage site MTPD325 was detected in the
parental protein species (Figures 7A and 7B), and peptides cor-
responding to both C- and N-terminal products of proteolysis
were detected in bands 12 and 22, respectively (Figures 7A,
7C, and 7D). In most cases, it was possible to place the half-tryp-
tic peptide precisely at the boundary of a persistent fragment,
which bolstered confidence in the accuracy and validity of cleav-
age site assignment (Figure 7E; also see Figure 3D). Interestingly,
in many instances where explicit cleavage sites were not
detected, the topographical coverage provided by PROTOMAP
was sufficient to identify implicit cleavage sites matching
caspase consensus sequences. Indeed, literature searches
revealed that several of these implicit cleavage events corre-
sponded to validated sites of caspase-mediated proteolysis.
Two representative examples, proteins DNM2 and SATB1, are
shown in Figure 7F. Extrapolating from these results, candidate
caspase proteolysis sites could also be predicted for other
cleaved proteins (e.g., JMJD1B; Figure 3C).
DISCUSSION
The large number of proteases encoded by the human genome
underscores the pervasive role of proteolytic pathways in biolog-
ical processes. A complete picture of endogenous substrates
is, however, lacking for most, if not all, human proteases. To
address this challenge, we developed PROTOMAP, a conceptu-
ally simple and robust method that combines the exceptional
resolution of intact proteins afforded by 1D-SDS-PAGE with
the orthogonal separation and high sensitivity of shotgun
LC-MS/MS. Information on the size of parental proteins and their
proteolytic fragments is preserved by recording gel migrationrates, which, when integrated with peptide sequence coverage
and spectral count data acquired by LC-MS/MS, provide a holis-
tic view of proteolytic cleavage events in native proteomes.
To evaluate the performance of PROTOMAP, we compared
the proteomes of normal and apoptotic Jurkat T cells. Apoptosis
has been intensively investigated by previous proteomic
methods (Brockstedt et al., 1998; Gerner et al., 2000; Schmidt
et al., 2007; Thiede et al., 2006; Van Damme et al., 2005) and,
thus, offered a good model system to evaluate the scope and
sensitivity of PROTOMAP. PROTOMAP identified more than
250 cleaved proteins in apoptotic cells, nearly two-thirds of
which corresponded to proteins not previously known to be
proteolyzed during apoptosis. Confidence in the accuracy of
cleaved protein assignments was bolstered by multiple lines of
experimental evidence, including western blotting and explicit
detection of many cleavage sites that match consensus
sequences for caspases (Table S4).
Perhaps the most striking feature of the PROTOMAP data sets
is the remarkable number of cleavage events that were found to
generate persistent protein fragments in apoptotic cells (Fig-
ure 5). We observed little correlation between the magnitude of
cleavage of the parental protein and the likelihood of generating
a persistent fragment (Figure S5), which indicates that these
fragments are not transient intermediates but, rather, exist in ap-
optotic cells for time periods that extend well beyond the half-life
of the parental protein. In further support of this notion, a time
course analysis revealed that the vast majority of fragments
are stable for at least 2 hr, with many persisting for hours after
complete degradation of their parental proteins (Figure 6 and
Table S3) and well beyond the time it takes STS to kill the majority
of Jurkat T cells (90% cell death by 4–6 hr posttreatment;
Na et al., 1996). Interestingly, persistent fragments often corre-
sponded to functional domains involved in a range of cellular
processes, including enzymatic catalysis, protein-protein inter-
actions, and protein-RNA/DNA interactions (Table S1). These
findings, in light of previous studies showing proapoptotic roles
for fragments of proteins such as PAK2 and ROCK1 (Coleman
et al., 2001; Rudel and Bokoch, 1997), suggest that the produc-
tion of active (or dominant-negative) protein effectors may be
a principal function of apoptotic proteolytic cascades. This could
be mechanistically accomplished, at least in part, by the evolu-
tionary introduction of caspase cleavage sites into interdomain
linker regions, which are frequently unstructured and, therefore,
readily accessible to proteases. One potential example of
this phenomenon is PRPSAP2, a protein that shares 44% overall
sequence identity with the purine-metabolizing enzyme phos-
phoribosylpyrophosphate synthetase 2 (PRPS2) (Figure S6).
High homology is observed throughout the two protein
sequences, except for one insertion segment in PRPSAP2Figure 6. Time Course Analysis of Proteolytic Events in Apoptotic Cells
(A) Rates of degradation of proteins could be divided into two general categories, rapid and slow, based on the quantity of parental species remaining at the 4 hr
time point following STS treatment (<50% versus >50% parental protein remaining, respectively). The time course of degradation is shown for all proteins in these
two categories, with the global averages indicated by dark lines.
(B–E) Global analysis of the temporal stability of persistent fragments (B). Most proteins displayed fragments that were highly persistent, being detected at either
all three time points (C) or two consecutive time points (D). A small fraction of proteins displayed transient persistent fragments (E) that were detected exclusively
at a single time point. See Table S3 for a complete list of time course profiles for cleaved proteins.
Spectral count data are represented as the mean ± SEM for three independent experiments.Cell 134, 679–691, August 22, 2008 ª2008 Elsevier Inc. 687
Figure 7. Mapping Precise Sites of Caspase-Mediated Proteolysis
(A–D) Peptograph for the cleaved protein U2AF2 (A), showing the locations of a peptide from the parental species that spans the exact site of cleavage (B), as well
as two half-tryptic peptides from persistent C-terminal and N-terminal fragments ([C] and [D], respectively). For each spectrum, dominant diagnostic y and b ions
are identified. All ions are in the +1 charge state unless otherwise indicated.
(E) Additional representative examples of explicit caspase cleavage sites identified by PROTOMAP that map to the ends of N- or C-terminal persistent fragments
(AP2A2 and UBE2O, respectively).688 Cell 134, 679–691, August 22, 2008 ª2008 Elsevier Inc.
(aa 218–248) that corresponds to an unstructured loop region
separating two domains (Figure S6). PRPSAP2 was identified
by PROTOMAP as a rapidly degraded protein in apoptotic cells
that generates a highly stable N-terminal fragment (Figures 6C
and S6). Interestingly, the precise site of cleavage was mapped
to the caspase consensus sequence DLVD223, which lies in
the middle of the unstructured loop region insertion. In contrast,
PRPS2, which lacks this insertion, was not cleaved in apoptotic
cells (Figure S6).
An overview of the data provided by PROTOMAP reveals
several advantages compared to previous methods for profiling
proteolytic pathways in proteomes. First, unlike peptide-labeling
techniques, PROTOMAP provides a complete topographical
description of the impact of proteolysis on protein structure, illu-
minating whether specific cleavage events generate persistent
N- or C-terminal fragments (orboth) and assigning predicted sizes
to these products. The value of this high-content information is
evident from a comparison of the data sets generated by
PROTOMAP and N-terminal labeling. The most extensive N-ter-
minal labeling study performed to date reported 50 proteins that
underwent caspase-mediated cleavage in apoptotic cells (Van
Damme et al., 2005). We identified 41 of these proteins by
PROTOMAP, and, for 24, the peptographs showed clear evi-
dence of protein cleavage (Table S5). In many of these cases,
PROTOMAP detected at least one persistent fragment with a
mass consistent with the previously defined site of caspase-
mediated proteolysis. However, in most instances, only a subset
of the total possible persistent fragments was observed for the
cleaved protein (i.e., either an N- or C-terminal fragment was de-
tected, but not both) (Table S5). PROTOMAP further revealed
clear examples, such as the splicing factor SF3B2, where internal
fragments were generated from multiple caspase-mediated
cleavage events (Figure S8), only one of which was detected by
N-terminal labeling. These findings demonstrate that PROTOMAP
discerns both the stability and structure of cleavage products of
proteins, parameters that cannot be inferred from an analysis of
sites of proteolysis alone. PROTOMAP also circumvents several
limitations of other gel-based techniques for profiling proteolytic
events. Specifically, PROTOMAP obviates the need for gel-based
visualization of candidate cleavage events by protein staining,
which contributed to substantial increases in sensitivity and pro-
teome coverage. Indeed, several previous efforts using 1- and
2-DGE have collectively identified only 49 cleaved proteins in ap-
optotic cells (Brockstedt et al., 1998; Gerner et al., 2000; Thiede
et al., 2005, 2006).
In considering potential limitations of PROTOMAP and areas
for future methodological improvement, one important challenge
relates to the identification of explicit sites of proteolytic cleav-
age. Although we did not originally design PROTOMAP with the
intention of detecting exact cleavage sites, we were pleasantly
surprised that the extensive sequence coverage provided by
this platform resulted in the identification of 61 distinct proteins
for which one or more precise caspase cleavage sites were
mapped in apoptotic cells (Table S4). A substantial fraction of
the caspase cleavage sites identified by PROTOMAP has notbeen previously reported (Table S4). Thus, these proteolytic
events serve as a rich source of information on the endogenous
substrate profiles of caspases. In this context, comparison of
our PROTOMAP data to a recent mRNA display study that map-
ped caspase substrates in vitro using recombinant proteins is
illuminating (Ju et al., 2007). In at least two cases (GAPVD1 and
TFG), the detailed topography provided by PROTOMAP permit-
ted assignment of explicit cleavage sites to proteins that bore
multiple consensus caspase cleavage sequences within the
protein fragment profiled by mRNA display (Figure S9). Thus,
PROTOMAP was able to both confirm the physiological rele-
vance of these proteolytic events in apoptotic cells and deter-
mine which of several candidate sites is endogenously cleaved.
It is notable that the data for TFG fell far below our original spectral
count threshold for quantitative analysis (11 total spectral counts
for TFG; 30 total spectral counts for quantitative analysis),
suggesting that PROTOMAP likely identified many additional
low-abundance and legitimate cleavage events that, for the pur-
pose of limiting false positives, we have refrained from analyzing
in this study. Indeed, more than 100 additional putatively cleaved
proteins were found in the subthreshold data, including several
established markers of apoptosis (e.g., caspase 8, STK3, and
CBL) (Graves et al., 1998; Widmann et al., 1998; Table S2), as
well as 20 additional explicit cleavage sites (Table S4). N-terminal
labeling studies have also uncovered several proteolytic events in
apoptotic cells that are non-caspase mediated (Enoksson et al.,
2007), and it is possible that some of the cleaved proteins identi-
fied by PROTOMAP may result from the activity of other prote-
ases activated during apoptosis (e.g., HtrA1, calpains, cathep-
sins). Collectively, these results indicate that further efforts to
improve the sensitivity and refine the analysis of PROTOMAP
data should yield an even larger number of proteins that can be
quantitatively profiled and provide enhanced sequence coverage
to facilitate the mapping of explicit sites of proteolysis.
A second area of potential concern for PROTOMAP is the limit
of resolution afforded by 1-DGE. Although very small changes in
mass (<5%) will likely prove difficult to detect, it is important to
point out that PROTOMAP was able to identify proteins display-
ing 10%–20% shifts in size across a large mass range (20–200
kDa), indicating that excellent overall resolution can be achieved
even when analysis is performed on a single 10% acrylamide
SDS-PAGE gel. Further improvements in resolution of very large
or small proteins could likely be achieved by varying the percent-
age of acrylamide in the SDS-PAGE gel. There are, of course,
events besides proteolysis that can alter the migration of pro-
teins by 1-DGE, including phosphorylation, glycosylation, and al-
ternative splicing. Considering that the vast majority of predicted
cleaved proteins identified by PROTOMAP showed multiple lines
of evidence indicative of proteolysis (e.g., conversion to one or
more persistent fragments, reductions in the quantity of parental
protein, and/or presence of an explicit caspase cleavage event),
we do not believe that nonproteolytic events contributed signif-
icantly to the data acquired in this study.
In summary, PROTOMAP constitutes a robust and versatile
strategy for the global analysis of proteolytic pathways in(F) Representative examples of established caspase cleavage sites that can be implicitly assigned by PROTOMAP (DNM2 and SATB1, respectively).
Spectral count data are represented as the mean ± SEM for four independent experiments.Cell 134, 679–691, August 22, 2008 ª2008 Elsevier Inc. 689
proteomes that complements and, in many ways, surpasses pre-
viously reported methods. A remarkable quantity of high-content
information pertaining to proteolytic pathways in apoptotic cells
was acquired by PROTOMAP, which, in turn, engenders hypoth-
eses about the biochemical pathways that support this complex
and important cellular process. Projecting beyond apoptosis, we
believe that PROTOMAP will serve as a generally useful platform
to characterize proteolytic pathways in a wide range of (patho)-
physiological processes, including tissue development, cancer,
inflammation, and infectious disease.
EXPERIMENTAL PROCEDURES
Cell Culture and Induction of Apoptosis
Jurkat cells were grown under standard conditions and seeded to a density of
1 3 106 cells/ml prior to induction of apoptosis. Staurosporine (1 mM) was
added, and the cells were incubated for 2, 4, or 6 hr at 37C prior to lysis.
See Supplemental Experimental Procedures for more detail.
Sample Preparation, SDS-PAGE, and LC-MS
100mg of cytosolic protein was separated via a 10% SDS-PAGE gel and cut into
22 0.5 cm bands. Bands were subjected to in-gel trypsin digestion using stan-
dard procedures, and resulting peptides were pressure-loaded onto a 100 mm
(inner diameter) fused silica capillary column containing 10 cm of C18 resin.
Peptides were eluted from the column using a 2 hr gradient with a flow rate of
0.25 ml/min directly into an LTQ ion trap mass spectrometer (ThermoFisher).
The LTQ was operated in data-dependent scanning mode, with one full MS
scan followed by seven MS/MS scans of the most abundant ions with dynamic
exclusion enabled.See Supplemental Experimental Procedures for more detail.
Data Analysis
Raw MS/MS data were searched using the SEQUEST algorithm using a con-
catenated target/decoy variant of the human IPI database, allowing for differ-
ential methionine oxidation and requiring static cysteine alkylation. SEQUEST
data from each band were filtered and sorted with DTASelect with the follow-
ing parameters: peptides were required to be tryptic on at least one terminus,
and the other terminal residue were allowed to be lysine, arginine, or aspartate.
The minimum required deltaCN was 0.8, and peptides in the +1, +2, and +3
charge states were required to have minimum XCorr values of 1.8, 2.5, and
3.5, respectively. Filtered proteomic data were organized and assembled
into peptographs using three custom perl scripts. Using these methods, our
false-positive rate for peptides was found to be less than 0.01%. All of the
custom scripts are available from our website (http://www.scripps.edu/
chemphys/cravatt/protomap), and this analysis is described in full detail in
the Supplemental Experimental Procedures.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures, ten
figures, and five tables and can be found with this article online at http://
www.cell.com/cgi/content/full/134/4/679/DC1/.
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